---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-032299"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2025-04-16T23:59:59+00:00"
generated_at: "2026-05-23T13:56:40.371672+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Denali Capital shareholders approve extension to Dec 2025; ~708K shares redeemed for ~$8.6M

## Summary
- Shareholders voted to extend business combination deadline to December 11, 2025, via up to 8 monthly extensions.
- Holders of ~708,098 Class A shares redeemed for ~$8.6M (~$12.17/share); only 43,739 Class A shares remain outstanding.
- Company deposited $874.78 into trust for first extension to May 11, 2025, funded by Scilex convertible note (up to $180K).
- Scilex note bears no interest, convertible at $10/share; remaining $58,670.30 available for future extensions.

## SEC filing metadata
- accession: 0001213900-25-032299
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2025-04-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390025032299/0001213900-25-032299-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390025032299/ea0238488-8k_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-032299
- JSON: https://secwatch.observer/filing/0001213900-25-032299.json
- Plain text: https://secwatch.observer/filing/0001213900-25-032299.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.